Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T63966 | Target Info | |||
Target Name | Vascular endothelial growth factor receptor 1 (FLT-1) | ||||
Synonyms |
Vascular permeability factor receptor; VEGFR1; VEGFR-1; VEGF-1 receptor; Tyrosine-protein kinase receptor FLT; Tyrosine-protein kinase FRT; Fms-like tyrosine kinase 1; FRT; FLT
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | FLT1 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Vascular endothelial growth factor receptor 2 (KDR) | Successful Target | ||||
UniProt ID | VGFR2_HUMAN | |||||
Gene Name | KDR | |||||
Synonyms |
VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyrosine kinase receptor flk-1; Kinase insert domain receptor; Fetal liver kinase 1; FLK1; FLK-1; CD309
Click to Show/Hide
|
|||||
Representative Drug(s) | Tivozanib | Drug Info | IC50 = 0.16 nM | Click to Show More | [1] | |
2 | Famitinib | Drug Info | IC50 = 2 nM | [2] | ||
3 | CEP-11981 | Drug Info | IC50 = 4 nM | [4] | ||
4 | E-3810 | Drug Info | IC50 = 25 nM | [5] | ||
5 | E-3810 | Drug Info | IC50 = 25 nM | [7] | ||
Co-Target Name | Tyrosine-protein kinase Kit (KIT) | Successful Target | ||||
UniProt ID | KIT_HUMAN | |||||
Gene Name | KIT | |||||
Synonyms |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; p145 c-kit; Proto-oncogene tyrosine-protein kinase Kit; Proto-oncogene c-Kit; Piebald trait protein; PBT; Mast/stem cell growth factor receptor Kit; CD117 antigen; CD117; C-kit
Click to Show/Hide
|
|||||
Representative Drug(s) | Famitinib | Drug Info | IC50 = 2 nM | [2] | ||
Co-Target Name | Platelet-derived growth factor receptor alpha (PDGFRA) | Successful Target | ||||
UniProt ID | PGFRA_HUMAN | |||||
Gene Name | PDGFRA | |||||
Synonyms |
RHEPDGFRA; Platelet-derived growth factor receptor 2; Platelet-derived growth factor alpha receptor; PDGFR2; PDGFR-alpha; PDGFR-2; PDGF-R-alpha; CD140a antigen; CD140a; CD140 antigen-like family member A; Alpha-type platelet-derived growth factor receptor; Alpha platelet-derived growth factor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Tivozanib | Drug Info | IC50 = 2.26 nM | Click to Show More | [3] | |
2 | CEP-11981 | Drug Info | IC50 = 246 nM | [4] | ||
Co-Target Name | Tropomyosin-related kinase A (TrkA) | Successful Target | ||||
UniProt ID | NTRK1_HUMAN | |||||
Gene Name | NTRK1 | |||||
Synonyms |
gp140trk; Tyrosine kinase receptor A; Tyrosine kinase receptor; Trk-A; TRKA; TRK1-transforming tyrosine kinase protein; TRK1 transforming tyrosinekinase protein; TRK; P140-TrkA; Neurotrophic tyrosine kinase receptor type 1; NGF-trk receptor type A; MTC; High affinity nerve growth factor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 3 nM | [4] | ||
Co-Target Name | Platelet-derived growth factor receptor beta (PDGFRB) | Successful Target | ||||
UniProt ID | PGFRB_HUMAN | |||||
Gene Name | PDGFRB | |||||
Synonyms |
Platelet-derived growth factor receptor 1; PDGFR1; PDGFR-beta; PDGFR-1; PDGFR; PDGF-R-beta; CD140b antigen; CD140b; CD140 antigen-like family member B; Beta-type platelet-derived growth factor receptor; Beta-PDGFR; Beta platelet-derived growth factor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Famitinib | Drug Info | IC50 = 4 nM | [2] | ||
Co-Target Name | BDNF/NT-3 growth factors receptor (TrkB) | Successful Target | ||||
UniProt ID | NTRK2_HUMAN | |||||
Gene Name | NTRK2 | |||||
Synonyms |
Tropomyosin-related kinase B; TrkB tyrosine kinase; Trk-B; TRKB; Neurotrophic tyrosine kinase receptor type 2; GP145-TrkB
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 5 nM | [4] | ||
Co-Target Name | Proto-oncogene c-Ret (RET) | Successful Target | ||||
UniProt ID | RET_HUMAN | |||||
Gene Name | RET | |||||
Synonyms |
RET51; RET receptor tyrosine kinase; RET mutant Y791F; RET mutant V804M; RET mutant V804L; RET mutant S891A; RET mutant M918T; RET mutant G691S; Proto-oncogene tyrosine-protein kinase receptor Ret; PTC; Cadherin family member 12; CDHR16; CDHF12; C-ret
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 5 nM | [4] | ||
Co-Target Name | Fibroblast growth factor receptor 1 (FGFR1) | Successful Target | ||||
UniProt ID | FGFR1_HUMAN | |||||
Gene Name | FGFR1 | |||||
Synonyms |
c-fgr; bFGF-R-1; bFGF-R; N-sam; HBGFR; Fms-like tyrosine kinase 2; FLT2; FLT-2; FLG; FGFR-1; FGFBR; CEK; CD331 antigen; CD331; Basic fibroblast growth factor receptor 1; BFGFR
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 13 nM | Click to Show More | [4] | |
2 | E-3810 | Drug Info | IC50 = 17.5 nM | [5] | ||
3 | E-3810 | Drug Info | IC50 = 17.5 nM | [6] | ||
Co-Target Name | Proto-oncogene c-Src (SRC) | Successful Target | ||||
UniProt ID | SRC_HUMAN | |||||
Gene Name | SRC | |||||
Synonyms |
pp60c-src; Tyrosine kinase (pp60(src)); Src tyrosine kinase; SRC1; Proto-oncogene tyrosine-protein kinase Src; Pp60(src); P60-Src; C-src TK; C-Src
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 37 nM | [4] | ||
Co-Target Name | Fms-like tyrosine kinase 3 (FLT-3) | Successful Target | ||||
UniProt ID | FLT3_HUMAN | |||||
Gene Name | FLT3 | |||||
Synonyms |
Stem cell tyrosine kinase 1; STK1; STK-1; Receptor-type tyrosine-protein kinase FLT3; Fetal liver kinase-2; FLT-3; FLK2; FLK-2; FL cytokine receptor; CD135
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 71 nM | [4] | ||
Co-Target Name | Fibroblast growth factor receptor 2 (FGFR2) | Successful Target | ||||
UniProt ID | FGFR2_HUMAN | |||||
Gene Name | FGFR2 | |||||
Synonyms |
Keratinocyte growth factor receptor 2; Keratinocyte growth factor receptor; KSAM; KGFR; K-sam; FGFR-2; FGF-2 receptor; CD332; BEK
Click to Show/Hide
|
|||||
Representative Drug(s) | E-3810 | Drug Info | IC50 = 82.5 nM | Click to Show More | [5] | |
2 | E-3810 | Drug Info | IC50 = 82.5 nM | [6] | ||
Co-Target Name | Tyrosine-protein kinase BTK (ATK) | Successful Target | ||||
UniProt ID | BTK_HUMAN | |||||
Gene Name | BTK | |||||
Synonyms |
Bruton's tyrosine kinase; Bruton tyrosine kinase; BPK; B-cell progenitor kinase; B cell progenitor kinase; Agammaglobulinemia tyrosine kinase; Agammaglobulinaemia tyrosine kinase; AGMX1
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 93 nM | [4] | ||
Co-Target Name | ALK tyrosine kinase receptor (ALK) | Successful Target | ||||
UniProt ID | ALK_HUMAN | |||||
Gene Name | ALK | |||||
Synonyms |
CD246; Anaplastic lymphoma kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 132 nM | [4] | ||
Co-Target Name | Adenosine A2a receptor (ADORA2A) | Successful Target | ||||
UniProt ID | AA2AR_HUMAN | |||||
Gene Name | ADORA2A | |||||
Synonyms |
Adenosine receptor A2a; ADORA2; A2a Adenosine receptor; A(2A) adenosine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | Ki = 500 nM | [4] | ||
Co-Target Name | Vascular endothelial growth factor receptor 3 (FLT-4) | Clinical trial Target | ||||
UniProt ID | VGFR3_HUMAN | |||||
Gene Name | FLT4 | |||||
Synonyms |
VEGFR3; VEGFR-3; VEGF-3 receptor; Tyrosine-protein kinase receptor FLT4; Fms-like tyrosine kinase 4
Click to Show/Hide
|
|||||
Representative Drug(s) | Tivozanib | Drug Info | IC50 = 0.24 nM | Click to Show More | [5] | |
2 | E-3810 | Drug Info | IC50 = 10 nM | [5] | ||
3 | E-3810 | Drug Info | IC50 = 10 nM | [7] | ||
Co-Target Name | Ephrin type-B receptor 2 (EPHB2) | Clinical trial Target | ||||
UniProt ID | EPHB2_HUMAN | |||||
Gene Name | EPHB2 | |||||
Synonyms |
hEK5; Tyrosine-protein kinase receptor EPH-3; Tyrosine-protein kinase TYRO5; TYRO5; Renal carcinoma antigen NY-REN-47; Receptor protein-tyrosine kinase HEK5; EphB2 receptor tyrosine kinase; EphB2; EPTH3; EPHT3; EPH-like kinase 5; EPH tyrosine kinase 3; ELK-related tyrosine kinase; EK5; Developmentally-regulated Eph-related tyrosine kinase; DRT
Click to Show/Hide
|
|||||
Representative Drug(s) | Tivozanib | Drug Info | IC50 = 17.5 nM | [3] | ||
Co-Target Name | Angiopoietin 1 receptor (TEK) | Clinical trial Target | ||||
UniProt ID | TIE2_HUMAN | |||||
Gene Name | TEK | |||||
Synonyms |
hTIE2; VMCM1; VMCM; Tyrosine-protein kinase receptor TIE-2; Tyrosine-protein kinase receptor TEK; Tyrosine kinase with Ig and EGF homology domains-2; Tunica interna endothelial cell kinase; TIE2; P140 TEK; Endothelial tyrosine kinase; Endothelial Cell-Specific Receptor TIE-2; CD202b antigen; CD202b
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 22 nM | [4] | ||
Co-Target Name | Aurora kinase A (AURKA) | Clinical trial Target | ||||
UniProt ID | AURKA_HUMAN | |||||
Gene Name | AURKA | |||||
Synonyms |
hARK1; Serine/threonine-protein kinase aurora-A; Serine/threonine-protein kinase 6; Serine/threonine-protein kinase 15; Serine/threonine kinase 15; STK6; STK15; IAK1; Breast tumor-amplified kinase; BTAK; Aurora/IPL1-related kinase 1; Aurora-related kinase 1; Aurora-A; Aurora 2; AYK1; AURA; ARK1; ARK-1; AIRK1; AIK
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 42 nM | [4] | ||
Co-Target Name | Macrophage colony-stimulating factor 1 receptor (CSF1R) | Clinical trial Target | ||||
UniProt ID | CSF1R_HUMAN | |||||
Gene Name | CSF1R | |||||
Synonyms |
Proto-oncogene c-Fms; M-CSF-R; FMS; CSF-1R; CSF-1-R; CSF-1 receptor; CD115
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 78 nM | [4] | ||
Co-Target Name | Fibroblast growth factor receptor 3 (FGFR3) | Clinical trial Target | ||||
UniProt ID | FGFR3_HUMAN | |||||
Gene Name | FGFR3 | |||||
Synonyms |
JTK4; FGFR-3; CD333
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 89 nM | Click to Show More | [4] | |
2 | E-3810 | Drug Info | IC50 = 237.5 nM | [6] | ||
Co-Target Name | Serine/threonine-protein kinase Chk2 (RAD53) | Clinical trial Target | ||||
UniProt ID | CHK2_HUMAN | |||||
Gene Name | CHEK2 | |||||
Synonyms |
hCds1; Hucds1; Checkpoint kinase 2; Cds1 homolog; Cds1; CHK2 checkpoint homolog; CHK2
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 140 nM | [4] | ||
Co-Target Name | Casein kinase I alpha (CSNK1A1) | Patented-recorded Target | ||||
UniProt ID | KC1A_HUMAN | |||||
Gene Name | CSNK1A1 | |||||
Synonyms |
Casein kinase I isoform alpha; CKI-alpha; CK1
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 48 nM | [4] | ||
Co-Target Name | Nuclear receptor subfamily 2 group C member 2 (NR2C2) | Co-Target | ||||
UniProt ID | NR2C2_HUMAN | |||||
Gene Name | NR2C2 | |||||
Synonyms |
Orphan nuclear receptor TAK1; Orphan nuclear receptor TR4; Testicular receptor 4
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 14 nM | [4] | ||
Co-Target Name | Serine/threonine-protein kinase MST2 (STK3) | Co-Target | ||||
UniProt ID | STK3_HUMAN | |||||
Gene Name | STK3 | |||||
Synonyms |
Serine/threonine-protein kinase 3; Mammalian STE20-like protein kinase 2; MST-2; STE20-like kinase MST2; Serine/threonine-protein kinase Krs-1
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-11981 | Drug Info | IC50 = 21 nM | [4] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors. Eur J Med Chem. 2010 Nov;45(11):5420-7. | ||||
REF 2 | Novel potent orally active multitargeted receptor tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of 2-indolinone derivatives. J Med Chem. 2010 Nov 25;53(22):8140-9. | ||||
REF 3 | Design, synthesis and biological evaluation of deuterated Tivozanib for improving pharmacokinetic properties. Bioorg Med Chem Lett. 2015 Jun 1;25(11):2425-8. | ||||
REF 4 | Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): a novel oncology therapeutic agent. J Med Chem. 2012 Jan 26;55(2):903-13. | ||||
REF 5 | Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors. J Med Chem. 2012 Dec 27;55(24):10797-822. | ||||
REF 6 | Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-1-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors. Eur J Med Chem. 2018 Jun 25;154:9-28. | ||||
REF 7 | An overview of the binding models of FGFR tyrosine kinases in complex with small molecule inhibitors. Eur J Med Chem. 2017 Jan 27;126:476-90. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.